期刊文献+

儿童肺炎链球菌对β-内酰胺类、大环内酯类和氟喹诺酮类抗菌药物敏感性研究 被引量:4

Resistance of Streptococcus Pneumoniae to β-lactams Macrolides and Fluoroquinolone among Children
下载PDF
导出
摘要 目的了解2002-2004年北京儿童医院门诊5岁以下呼吸道感染儿童鼻咽拭子中分离出的肺炎链球菌,对β-内酰胺类、大环内酯类和氟喹诺酮类抗菌药物的耐药性.方法使用E试验法(E-test)对114株肺炎链球菌进行抗菌药物的敏感性试验.结果114株肺炎链球菌对青霉素不敏感率为36%,对阿莫西林/棒酸全部敏感,对头孢菌素中头孢曲松不敏感率为6.1%,头孢呋辛为30.7%,头孢克洛为29%,大环内酯类耐药率在90%左右,全部菌株对氟喹诺酮类敏感.结论儿童肺炎链球菌对青霉素和头孢二代抗菌药物不敏感率为29%~36%,对大环内酯类耐药在90%左右,未发现对氟喹诺酮类耐药菌株. Objective To investigate resistance to β-1actams, macrolides and fluoroquinolone in carriage isolates of Streptococcus pneumoniae in nasopharynx among children under 5 with respiratory infection who attended a general outpatient department at Beijing Children's Hospital from 2002 to 2004. Methods Antimicrobials sensitivity testing of Streptococcus pneumoniae E-test methods and the results were analyzed according to NCCLS (2002). Results Resistance of pneumococci to penicillin was 36%, amoxycillin/clavulanate was 0 % , ceftriaxone was 6.1% , cefaclor was 29 % , cefuroxime was 30.7 % , macrolides were around 90% , and fluoroquinolone were 0%. Conclusion Non-susceptible to penicillin and the second cephalosporin of Streptococcus pneumoniae isolates among children ranged from 29 % -36 % , and to macrolides were about 90 %.
出处 《首都医科大学学报》 CAS 2005年第5期517-520,共4页 Journal of Capital Medical University
基金 国家自然科学基金(30070793) 北京市科委基金(Y0204004040131)资助项目
关键词 肺炎链球菌 细菌耐药 氟喹诺酮类抗菌药物 Streptococcus pneumoniae bacterial resistance fluoroquinolone
  • 相关文献

参考文献19

二级参考文献73

  • 1李家泰,魏瑾.甲氧西林耐药金葡菌(MRSA)感染的诊断与治疗[J].中国临床药理学杂志,1993,9(2):97-108. 被引量:24
  • 2魏瑾,李家泰.多聚酶链反应(PCR)技术在甲氧西林耐药金葡菌检测中的应用[J].中国临床药理学杂志,1994,10(1):42-49. 被引量:2
  • 3Montanaxi MP, Mingoia M, Giovanetti E, et al. Differentiation of resistant phenotype among erythromycin-resistant pneumococci. J Clin Microb,2001,39(4) :1311. 被引量:1
  • 4Ip M, Lyon D, Yung RWH, et al. Macrolide resistance in strepto coccus pneumoniae in Hong Kong. Antimicrob Agents Chemother,2000,45(5 ) :1578. 被引量:1
  • 5Gay K, Baughuman W, Miller Y, et al. The emergence of streptococcus pueumonia resistant to macrolide antimicrobial agents:a 6-year population-based assessment. J Infect Dis, 2000,182 ( 8 ): 1147. 被引量:1
  • 6Angot P, Vergnaud M ,Auzou M,et al. Macrolide resistant phenotype and genotypes in French clinical isolates of streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis,2000,19(10) :755. 被引量:1
  • 7Hoban D J, Wierzbowski AK, Nichol K, et al. Macrolide-resistant streptococcus pneumordae in Canada during 1998-1999: prevalence of mef (A) and erm (B) and susceptibilities to ketolides. Antimicrob Agents Chemother,2001,45(7 ) :2147. 被引量:1
  • 8Fitoussi F, Doit C, Geslin P, et al. Mechanisms of macrolide resistance in clinical pneumocoecal isolates in France. Antimicrob Agents Chemother ,2001,45 (2) :636. 被引量:1
  • 9Schndtz FJ, Perdikouli M, Beek A, et al. Molecular surveillance of macrolide ,tetracycline and quinolone resistance mechanisms in 1191 clinical European streptococcus pneumoniae isolates. Int J Antimicrob Agents,2001,18(2) :433. 被引量:1
  • 10Mcgee L, Wang H, Wasas A, et al. Prevalence of serotype and molecular epidemiology of streptococcus pneumoniae strain isolated from children in Beijing, China:identification of two novel multiply-resistant clones. Microb Drug Resist,2001,7( 1 ) :55. 被引量:1

共引文献800

同被引文献48

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部